Lv0
0 积分 2025-05-19 加入
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
11小时前
待确认
Artificial intelligence‐based reticulin proportionate area – a novel histological outcome predictor in hepatocellular carcinoma
11小时前
已完结
皖公网安备34019202002308
